Massive Bio has made its inaugural strategic investment in Rivvi. Read the announcement

2027 Star Ratings

H4054

Provider Partners Health Plans

2,557 members

4

-1.0 vs 2026On the 4 star line

Ask about H4054

3 free questions today

Medication adherence

Medication Adherence for Diabetes Medications

4 · 2.0 pt to 5★

Medication Adherence for Hypertension (RAS antagonists)

1 · 5.0 pt to 2★

Medication Adherence for Cholesterol (Statins)

3 · 2.0 pt to 4★

All measures

MeasureStarsScore
C27 Complaints about the Health Plan40.21
C28 Members Choosing to Leave the Plan56%
C17 Plan All-Cause Readmissions3x58%
C01 Breast Cancer Screening155%
C31 Reviewing Appeals Decisions178%
C13 Kidney Health Evaluation for Patients with Diabetes480%
C02 Colorectal Cancer Screening582%
C11 Diabetes Care – Eye Exam588%
C12 Diabetes Care – Blood Sugar Controlled3x592%
C32 Call Center – Foreign Language Interpreter and TTY Availability394%

Other plans from this organization

Source: CMS 2027 Part C and D Star Ratings data, released October 8, 2026. Data loaded October 9, 2026.

Try it on your own data today.

Free to start. Most teams are using it the same day.